Biomolecules such as exosomal PD-L1 and miRNAs have shown utility in predicting response to immune checkpoint inhibitors and tracking disease progression in cancers such as melanoma, breast, ovarian, and bladder cancer (7–10). The gene discussed is CD274; the disease is cancer.